NFGH
HELP

Nan Fung Group Holdings’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Nan Fung Group Holdings’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.53M Buy
987,222
+527,222
+115% +$2.64M 4.96% 4
2026
Q1 		$2.21M Hold
460,000
– – 1.82% 14
2025
Q4 		$3.76M Buy
+460,000
New +$2.96M 3.37% 10

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Nan Fung Group Holdings's HELP Position: Q2 2026 in Review

Nan Fung Group Holdings increased its Helus Pharma Inc. Common Stock (HELP) stake by 115% in Q2 2026, buying an estimated $2.64M and bringing the position to 987,222 shares worth $6.53M. The position accounts for 4.96% of the portfolio, ranked #4.

Nan Fung Group Holdings first reported a position in HELP in Q4 2025 and has held it in 3 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Nan Fung Group Holdings held 987,222 shares of Helus Pharma Inc. Common Stock worth $6.53M as of Q2 2026.
  • Nan Fung Group Holdings bought 527,222 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $2.64M.
  • Helus Pharma Inc. Common Stock made up 4.96% of Nan Fung Group Holdings's portfolio in Q2 2026, its #4 holding.
  • Nan Fung Group Holdings first reported a position in Helus Pharma Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.